LB Corp (LBRX) Cash Money per Share

LB Pharmaceuticals Inc - graphic logo of issuer LBRX

LB Pharmaceuticals Inc (LBRX) relies on diversified distribution channels for psychotropic drugs to protect its margins. This cash per share chart visualizes liquidity, where the current figure stands at 12.51. However, the absence of a retail market and dependence on the FDA create risks. Meanwhile, patent protection for innovative schizophrenia treatments should ensure high therapy costs.

LB Pharmaceuticals (LBRX) - Cash per Share from 09/12/2025 to 11/20/2026

Analytical breakdowns for LB Pharmaceuticals Inc

- share price and expert price forecast:
- cash availability and cash flow indicators:
Summary company analysis:LBRX, LB Pharma
Flagship merchandise of LB Pharmaceuticals

To minimize investment risks, it is necessary to evaluate the issuer's liquidity cushion via the ratio of total cash to the number of shares outstanding. The trend in cash per share analysis demonstrates the ability of LB Pharmaceuticals Inc (LBRX) to fund the development of safe drugs for psychosis therapy, ensuring the company's financial stability amid growing demand from specialized clinics.